Journal of Advanced Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-10-31 静心大魔女来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：lipid metabolism
经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。

88 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-04-16 Luck 来自湖南省

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：医学
经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。

29 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2022-01-18 ms3000001224934147

求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？

102 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2022-11-22 mmz666

今年能进一区吗？

41 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-01-03 120463b1m13(暂无昵称) 来自广东省

大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2021-12-30 ms5000002112552282

求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀

55 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-12-19 ms1000001648241944 来自贵州省

审稿速度:6.0
偏重的研究方向：肿瘤;代谢;免疫细胞
经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view

87 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-02-19 ms6000001830956975

审稿速度:3.0 | 投稿命中率:50.0
经验分享：一直在技术审查。

30 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-06-14 ms3000001065544020 来自浙江省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：癌症;实验
经验分享：特别慢特别慢再说一次特别慢
极其不负责任，发邮件都是客套话
没人理
审稿人送了一波又一波一定要三个四个才回来

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165947, encodeId=be0b216594e1e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：lipid metabolism 经验分享：格式审查了三遍，提交后送审，审稿差不多一个月，给了三周修稿时间，然后我们延迟了两周，五周后投回去，三天后重新送审，两周左右两个审稿人完成了审稿，目前正在decision in process，不知道会是什么结果。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BqCPu9GVaq3OgIeibDXe6pgqb10Ex1wtyEdx42siawAeWZpd8NS9fcoTheXYZqo87BbvOEuCdxaHTnoiaSjmo1aaA/132, createdBy=30c32289387, createdName=静心大魔女, createdTime=Tue Oct 31 19:05:48 CST 2023, time=2023-10-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126332, encodeId=955f2126332e9, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：医学 经验分享：2022年10 月30日投稿，12月12日返回审稿意见，两个审稿人一起提了14点意见，大多是关于表达的，要求必须补充两个实验并且必须润色，编辑（主编）给的大修，因为实验难度很大，但还是决定补充，艰难的补了两个月实验，当时还正值过年，之后送到润色公司润色了一周，审稿人提的所有要求全部按照修稿并表示感谢，2023年2月18日返回修改稿，编辑等了一个月才返给审稿人。审稿人审稿很快，4月9日主编返回意见，直接拒稿，没有任何审稿意见，一句话达不到杂志要求。申诉也不回任何信息，投稿周期半年时间，还有一个多月毕业，真的想骂人，这沙比杂志。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79675397202, createdName=Luck, createdTime=Sun Apr 16 19:23:45 CST 2023, time=2023-04-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1185774, encodeId=089a1185e74d6, content=求问要所有作者都确认了才能pending technical assessment状态才能继续推进吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=118b6402626, createdName=ms3000001224934147, createdTime=Tue Jan 18 21:38:11 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101938, encodeId=ef76210193849, content=今年能进一区吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fa046123, createdName=mmz666, createdTime=Tue Nov 22 11:04:11 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108611, encodeId=9168210861190, content=大家好，文章接收半年后还没正式出版，没有卷刊期号，pubmed上能搜到，大家知道怎么回事嘛？有遇到这种情况不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/JkB1YlmwTBRhMdXyXjOib139icth7rLdATJWIwJic59MDFHgVRQcAGmy4STqNe5EwnNcpOVrTNmic0UrhuwyfTbN4g/132, createdBy=b5b22167736, createdName=120463b1m13(暂无昵称), createdTime=Tue Jan 03 12:07:37 CST 2023, time=2023-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179031, encodeId=8a6011e90313e, content=求问大佬们，technical assessment后修改格式重投，两天with editor，编辑会直接拒稿吗，还是下一步直接等待送审，大概多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6faa6386109, createdName=ms5000002112552282, createdTime=Thu Dec 30 23:45:33 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175781, encodeId=cd0921e578189, content=审稿速度:6.0 偏重的研究方向：肿瘤;代谢;免疫细胞 经验分享：8月13日第一次投，18号技术让改格式，29又投回去。9月13改格式，14号with editor，18号under view。10月18号修回，23号修回去，，直至现在一直under view, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b958746065, createdName=ms1000001648241944, createdTime=Tue Dec 19 11:52:08 CST 2023, time=2023-12-19, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2115343, encodeId=3d8b2115343c0, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一直在技术审查。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e508484319, createdName=ms6000001830956975, createdTime=Sun Feb 19 00:25:26 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142722, encodeId=355c2142e2296, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：癌症;实验 经验分享：特别慢特别慢再说一次特别慢 极其不负责任，发邮件都是客套话 没人理 审稿人送了一波又一波一定要三个四个才回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80e05454482, createdName=ms3000001065544020, createdTime=Wed Jun 14 11:54:56 CST 2023, time=2023-06-14, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2118620, encodeId=9e632118620c1, content=2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Fri Mar 10 09:26:54 CST 2023, time=2023-03-10, status=1, ipAttribution=)]

2023-03-10 1581f9a412m

2022年上半年投稿，至今过去快11个月了，还没有返回审稿意见。期间信息状态更新过2次。。。唉。。。真是慢哦。。。。

24 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务